Skip to navigation Skip to content

Advocate for Change

We are MS activists on the frontline, moving together and speaking with one clear voice to advance federal, state and community policies and programs that benefit people with MS and their families. Become an MS activist today.

Share

Current Priority Issues

Support the development of telehealth/telemedicine services to increase access to medical services i

Find out more

Find out more

National MS Society License Plate FAQ

What is a Society license plate?

Custom plates bear the logo of the National MS Society and are available to motorists who wish to contribute to the effort to find a cure for MS.

How much do they cost?

If you have a previous version of the Society plate, you can upgrade to the latest design for $28.75. First-time registrants can purchase the Society plate with a standard plate number assigned by DMV for an initial fee of $53.75. The annual fee of $25 is in addition to the standard registration renewal fee. The plate can also be personalized with a number between two and six characters long, including spaces, for an initial fee of $85. The annual renewal fee for a personalized Society plate is $56.25.

What is the money used for?

It is used to support the New York State MS Research Fund which supports pediatric MS research conducted at Jacobs Neurological Institute in Buffalo and the MS center at Stony Brook Long Island Children’s Hospital.

How do I obtain a Society license plate?

The Society plate is available in both passenger and commercial class. You can order it online at dmv.ny.gov or by calling the DMV Custom Plates Unit at (518) 402-4838, Monday through Friday, between 8 a.m. and 4 p.m., or by visiting any local DMV office.

Can I get a plate indicating I am disabled?

In addition to being available for passenger class vehicles, the Society plate is available with the International Symbol of Access (ISA) on it for any registrant with a disability who qualifies for such a plate. Any individual qualifying for an ISA must contact the Custom Plates Unit at 518-402-4838 before submitting an application.

Governor Cuomo Signs New York Step Therapy Bill

 

January 3, 2017 - New York Governor Andrew Cuomo kicked off 2017 by signing the Step Therapy Reform bill (S.3419C/A.2834D) this weekend, joining seven other states who have passed similar legislation in recent years. The bill was a top priority for MS activist in New York who made hundreds of calls, held in-person meetings, and posted to elected officials social media pages in a grassroots effort to drum up support for the bill. 

Known as "fail first," step therapy policy are a form of utilization management that health plans may use as a mechanism to control the order in which patients take certain therapies. Step therapy protocols require that patients must try at least one medication selected by their insurer before the plan will grant coverage for the drug originally prescribed by the healthcare provider. Through this method, insurers often require a patient to try a lower-cost drug or service, before they will cover a more expensive option.

S.3419C/A.2834D, which took effect January 1st, will regulate insurance companies, health maintenance organizations (HMOs), and utilization review agents who impose step therapy protocols on patients, and will provide an expedited appeals process for patients and their health care professionals to override such protocols.

The law will expedite the process of step therapy and specifically:
  • Require health insurance companies to provide patients and health care professionals with specific written information on their clinical review criteria relating to a decision made to utilize a step therapy protocol.
  • Define key terms such as "step therapy protocol override determination" and "Step therapy protocol."
  • Requires a utilization review agent to utilize evidenced-based and peer reviewed clinical review criteria that is appropriate for a patient's medical condition when establishing a step therapy protocol.
  • Provide an expedited process for patients and health care providers to override a step therapy protocol. A determination must be made within 24 hours of the receipt of all information from the patient and/or health care provider in emergency cases.
  • Establishes standards for an override determination. Upon a determination that the step therapy protocol should be overridden, the health plan must authorize immediate coverage for the prescription drug prescribed by the patient's treating health care provider.
  • Provides that if an insurance company or utilization review agent fails to respond within the required timeframes, the appeal shall be deemed granted in favor of the patient.

MS activist Karen Waldron and Advocacy Director Jennifer Muthig held an interview on Capital Tonight, as did Dr. Nilay Shah, to highlight to bills impact on people living with MS. Letters to the editor from MS activists were also placed in the Times Herald-Record, the Utica Observer Dispatch, and the Journal News (lohud).

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share


Chapter Home